Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Immunotherapy, Adoptive × Other hematologic neoplasm × Clear all

Status

Unknown 14 Recruiting 10 Active not recruiting 5 Not yet recruiting 3 Terminated 2 Withdrawn 1 Completed 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 1 Hematologic Neoplasms 1

Interventions

venetoclax 1 tisagenlecleucel 1 brexucabtagene autoleucel 1 asciminib 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04008524 2025-08-06

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

Institute of Hematology & Blood Diseases Hospital, China

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡